Medtech Venture Capital Decoded Insider Tips from Top Investors

The journey to medtech success is often paved with critical decisions about funding and partnerships. For many entrepreneurs, navigating the complex world of medtech venture capital can be daunting. During a panel at LSI USA ‘24, industry leaders Dennis McWilliams of Santé Ventures, Thom Rasche of Earlybird Venture Capital, Amir Soltanianzadeh of Solardis Health Ventures, Owen Willis of Opal Ventures, and life science investor Nancy Hong pulled back the curtain on how VCs operate, their investment philosophies, and the dynamics that shape funding in the medtech space.